ABUS

ABUS Change in Working Capital

-$177.17MTTM · USD

Period ending:

ABUS FY Change in Working CapitalUSD
ABUS FY Change in Working Capital1998-12-31: $55.19K1999-12-31: $20.04K2000-12-31: $106.07K2001-12-31: -$228.32K2002-12-31: $2.84M2003-12-31: -$1.96M2004-12-31: $1.64M2005-12-31: -$3.09M2006-12-31: -$552.78K2007-12-31: -$1.60M2008-12-31: $2.68M2009-12-31: $1.56M2010-12-31: -$529.32K2011-12-31: $1.11M2012-12-31: -$2.45M2013-12-31: $2.30M2014-12-31: $16.52M2015-12-31: -$14.63M2016-12-31: -$467.00K2017-12-31: $3.15M2018-12-31: -$4.28M2019-12-31: -$2.23M2020-12-31: $431.00K2021-12-31: $930.00K2022-12-31: $29.24M2023-12-31: -$18.23M2024-12-31: -$2.83M2025-12-31: -$10.02M$29.24M-$18.23M
1998-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ABUS change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.

Arbutus Biopharma Corp Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-10,023,000
-2,829,000
-18,233,000
29,243,000
930,000
431,000
-2,225,000
-4,275,000
3,147,000
-467,000
-14,631,000
16,519,000
2,297,630
-2,449,295
1,111,215
-529,323
1,561,766
2,679,887
-1,596,783
-552,783
-3,092,457
1,636,385
-1,959,742
2,836,323
-228,324
106,067
20,040
55,191

Compare change in working capital

All ABUS financial metrics · ABUS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.